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Angiotensinogen (Ao) is the obligatory glycoprotein substrate
for the enzymatic generation of the angiotensin peptides. There
are high concentrations of Ao in plasma, originating mostly from
hepatic biosynthesis. Numerous additional tissues which, among
others, include the heart, adrenal, kidney, pituitary and brain, also
express Ao [1]. The Ao synthesized by these tissues is available for
the local generation of angiotensins. Consequently, changes in the
availability of Ao via regulation of its synthesis and secretion is
likely to directly affect the activity of local angiotensin-generating
systems.
Regulation of Ao by glucocorticoids (GCs) has been investi-
gated mostly for liver where secretion and mRNA content in-
crease several-fold [2—4]. However, sensitivity to GCs is tissue-
specific and has been particularly difficult to show in brain tissue
[3, 5, 6]. In addition, it has been demonstrated in the liver that
GCs interact additively with cAMP and permissively with inter-
leukins [2, 4]. Recently we reported an inhibitory action of GC in
C6 glioma cells which could be prevented by cAMP and isopren-
aline [7]. Since GCs and cAMP are known to interact negatively
or positively in gene expression, depending on tissue [8, 9], it is
possible that the range of GC sensitivities reported for Ao results
from tissue specific interactions with cAMP or with some other
factor. We report recent data in which cell cultures of H4 (rat
hepatoma) and primary cultures of pituitary, astrocyte and neu-
ronal cells were used to investigate the interaction of the glucocor-
ticoid, dexamethasone (DEX) with cAMP.
Methods
Rat H4 hepatoma cells were cultured as described previously [7,
10]. One day before experiments, the medium was changed to a
serum-free formula supplemented with ITS (5 mg/ml insulin, 5
mg/transferrin, 5 ng/ml selenite). Pituitary cells were obtained
from adrenalectomized male Wistar rats; neuronal cells from
neonates and glial cells were from 21-day-old Sprague-Dawley
rats [6, 10]. Ao in the culture medium was measured by a direct
radioimmunoassay [6] and expressed as ng Ao per 106 cells or per
well (35 and 100 mm2 plates for glia and neurones, respectively).
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RNA was extracted and angiotensinogen mRNA detected by
RT-PCR using primers flanking positions 245-557 of the Ao
cDNA. The 312 bp product was separated on 1% agarose, stained
with ethidium bromide and quantified by image analysis. Dibu-
tyryl cyclic AMP (dBcAMP) was used as a cAMP analogue,
isoprenaline as a beta-adrenergic receptor agonist and 6-fluoro-
noradrenaline (6-FNA) as an aipha-adrenergic agonist. Group
values are expressed as mean SEM.
Results
Ao secretion from H4 cells increased with DEX treatment in a
dose-dependent manner from 103 5 (control) to 999 63
ng/106 cells/day with 1 LM DEX (Fig. 1A). The addition of 1 mri
dibutyryl cAMP increased the mean secretion by 340% compared
to that with Dex alone. Increasing the concentrations of dBcAMP
in the absence of Dex also increased secretion up to, but not above
2 mvi dBcAMP (Fig. 1B). Altering intracellular cAMP via the
beta-adrenoceptor agonist isoprenaline (0.1 j.LM) or the alpha
agonist 6-FNA (0.1 LM) had no effect on either basal or DEX-
stimulated secretion (data not shown). Primary pituitary cells
prepared from adrenalectomized rats were markedly responsive
to increasing concentrations of DEX, with a pronounced 20-fold
increase from 2.9 0.6 (control) to 57.7 5.6 ng Ao/106 cells/3
days at 0.1 M DEX (Fig. 2A). The addition of 1 m'vi dBcAMP
increased the mean secretion by 400% compared to that with Dex
alone. The Ao mRNA of the (1 .LM Dex + 1 mM dBcAMP) group
was 38-fold above the control (which was assigned a density of 1),
as measured by RT-PCR (Fig. 2B). However, neither isoprenaline
nor 6-FNA significantly changed basal or DEX-stimulated secre-
tion. Preparations of glia from 21-day-old rat brains did not
respond to DEX, dBcAMP or a combination of both (Fig. 3A).
Neuronal cells from one-day-old rat brains increased Ao secretion
by only 2.5-fold; dBcAMP had no effect (Fig. 3B).
Discussion
The stimulation of hepatic Ao by Dcx and the influence of
cAMP on this stimulation is in general agreement with previous
reports [2, 4], although discrepancies remain. Thus Ohtani et al
[4] found that cAMP enhanced the action of Dex in primary
hepatocytes but not in hepatoma cells. Ben-An and Garrison [2]
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Fig. 2. (A) Secretion of angiotensinogen by rat pituitaly cells in the presence
Fig. 1. (A) Stimulation of Ao secretion by H4 hepatoma cells by increasing of increasing concentrations of Dex with (R), or without (LII), I mMdBcAMP.
concentrations of Dex in the absence (LII) or presence () of] ms'i dBcAMP. (B) RT-PCR amplification of the Ao mRNA after stimulation by 1 ,sMN = 8 (B) The effect of increasing concentrations of dBcAMP on Ao Dex + 1 mivi dBcAMP. N = 4.
secretion in the absence of Dex. N = 8.
found the accumulation of Ao mRNA by cAMP and Dex to be been reported for the regulation of nerve growth factor [11]. We
additive, while our secretion data suggest a factorial synergism recently found an inhibitory action of Dex in glioma cells which
(Fig. 1), which is also supported by the RT-PCR data for the was antagonized by cAMP [7], suggesting that GC regulation of
pituitary (Fig. 2). It is noteworthy that we could not reproduce the Ao may include inhibitory as well as stimulatory actions, as
effects of exogenous cAMP with adrenergic agonists, even though observed in other hormonal systems [8, 9, 11].
our H4 cells express at least beta adrenoceptors (unpublished In conclusion, we have shown the presence of a marked tissue
observations). The results from primary pituitary cultures were specificity in the regulation of Ao by GCs and the positive
qualitatively similar to those of H4 cells, but quantitatively they involvement of cAMP. The molecular mechanisms at the regula-
were of much greater magnitude. The 40-fold increase in Ao tory region of the Ao gene which mediate the tissue-specific
mRNA induced by (Dex + cAMP) in control pituitary cells from
adrenalectomized rats, and the 100-fold increase in secretion by
the same two groups is unprecedented. Also, the greater effect on
actions of GCs and the interactions with cAMP have not been
investigated, but may be envisaged to involve the GRE and cAMP
responsive elements of the Ao gene [12].
secretion suggests the involvement of post-transcriptional mech-
anisms. The implications for the local pituitary Ang TI-generating
system remains to be explored. The relative insensitivity of the Acknowledgments
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